GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innoveren Scientific Inc (OTCPK:IVRN) » Definitions » Cyclically Adjusted PB Ratio

Innoveren Scientific (Innoveren Scientific) Cyclically Adjusted PB Ratio : 0.00 (As of May. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Innoveren Scientific Cyclically Adjusted PB Ratio?

As of today (2024-05-29), Innoveren Scientific's current share price is $0.0055. Innoveren Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $225.03. Innoveren Scientific's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Innoveren Scientific's Cyclically Adjusted PB Ratio or its related term are showing as below:

During the past years, Innoveren Scientific's highest Cyclically Adjusted PB Ratio was 0.02. The lowest was 0.01. And the median was 0.01.

IVRN's Cyclically Adjusted PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.75
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Innoveren Scientific's adjusted book value per share data for the three months ended in Sep. 2023 was $-15.908. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $225.03 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Innoveren Scientific Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Innoveren Scientific's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innoveren Scientific Cyclically Adjusted PB Ratio Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Innoveren Scientific's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Innoveren Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innoveren Scientific's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innoveren Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Innoveren Scientific's Cyclically Adjusted PB Ratio falls into.



Innoveren Scientific Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Innoveren Scientific's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0055/225.03
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Innoveren Scientific's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-15.908/129.8595*129.8595
=-15.908

Current CPI (Sep. 2023) = 129.8595.

Innoveren Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201312 286.222 98.326 378.015
201403 0.000 99.695 0.000
201406 159.667 100.560 206.189
201409 95.965 100.428 124.089
201412 709.487 99.070 929.988
201503 1,558.635 99.621 2,031.734
201506 1,140.962 100.684 1,471.583
201509 1,036.413 100.392 1,340.632
201512 907.059 99.792 1,180.353
201603 823.084 100.470 1,063.848
201606 102.022 101.688 130.286
201609 96.289 101.861 122.756
201612 -30.148 101.863 -38.434
201703 108.658 102.862 137.176
201706 44.185 103.349 55.519
201709 95.937 104.136 119.636
201712 33.696 104.011 42.070
201803 -7.281 105.290 -8.980
201806 -8.820 106.317 -10.773
201809 -57.307 106.507 -69.872
201812 -80.785 105.998 -98.971
201903 101.244 107.251 122.587
201906 124.623 108.070 149.751
201909 100.071 108.329 119.960
201912 -91.110 108.420 -109.126
202003 -116.119 108.902 -138.466
202006 -176.336 108.767 -210.531
202009 2.571 109.815 3.040
202012 -12.472 109.897 -14.738
202103 -19.095 111.754 -22.189
202106 -26.221 114.631 -29.704
202109 -28.262 115.734 -31.711
202112 -31.449 117.630 -34.719
202203 -18.418 121.301 -19.717
202206 -27.495 125.017 -28.560
202209 -17.981 125.227 -18.646
202212 -15.838 125.222 -16.425
202303 -18.734 127.348 -19.103
202306 -16.442 128.729 -16.586
202309 -15.908 129.860 -15.908

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Innoveren Scientific  (OTCPK:IVRN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Innoveren Scientific Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Innoveren Scientific's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Innoveren Scientific (Innoveren Scientific) Business Description

Traded in Other Exchanges
N/A
Address
2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
Executives
Fwhc Holdings, Llc 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Hoa Capital Llc 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Farrior J Rex Iii 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Fwhc Bridge Friends, Llc 10 percent owner 1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Raymond Monteleone director 201 E KENNEDY BLVD, STE 700, TAMPA FL 33602
Jeremy Daniel officer: Chief Financial Officer 201 E KENNEDY AVE, STE 700, TAMPA FL 33602
Robert Smith Greif officer: President and C.E.O. 19 MAY STREET, NEEDHAM MA 02492
Cfrs Investments, Llc 10 percent owner 2903 W VILLA ROSA PARK, TAMPA FL 33611
Frederick J Lynch 10 percent owner C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Fwhc Bridge, Llc 10 percent owner 334 EAST LAKE ROAD, SUITE 176, PALM HARBOT FL 34685
Todd R Wagner 10 percent owner 3385 OLD KEYSTONE ROAD, TARPON SPRINGS FL 34688
Michael Yurkowsky director 2380 OLD MILTON PARKWAY, ALPHARETTA GA 30009
William E Horne director, officer: Chief Executive Officer 201 EAST KENNEDY BLVD, SUITE 700, TAMPA FL 33602
Jon Mogford director 714 PLUM HOLLOW DRIVE, COLLEGE STATION TX 77845
John C Thomas director 8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615

Innoveren Scientific (Innoveren Scientific) Headlines